Attached files
| file | filename |
|---|---|
| EX-31 - EXHIBIT 31.2 - PEAK PHARMACEUTICALS, INC. | exh312.htm |
| EX-31 - EXHIBIT 31.1 - PEAK PHARMACEUTICALS, INC. | exh311.htm |
| EX-32 - EXHIBIT 32.2 - PEAK PHARMACEUTICALS, INC. | exh322.htm |
| 10-Q - FORM 10-Q - PEAK PHARMACEUTICALS, INC. | pkph10q20150630ver2clean.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Peak Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2015 (the “Report”), I, Soren Mogelsvang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and
2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.
Date: August 13, 2015
/s/Soren Mogelsvang, Chief Executive Officer